Thursday, March 5, 2015

Deals

TG Therapeutics, Checkpoint Therapeutics Commercialization Collaboration

March 4, 2015 · Leave a Comment 

  TG Therapeutics (NASDAQ: TGTX) an agreement with Checkpoint Therapeutics, Inc., a newly formed subsidiary of Coronado Biosciences, Inc. (Nasdaq: CNDO) to develop and commercialize Checkpoint’s fully human anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. Checkpoint will develop and commercialize these antibodies in solid tumors. The antibodies were generated in the laboratory of Dr. Wayne Marasco, MD, PhD, a Professor in the Department of Cancer Immunology and AIDs at Dana-Farber Cancer Institute (Dana-Farber). Both programs are currently... [Read the full story]

Deal News

TG Therapeutics, Checkpoint Therapeutics Commercialization Collaboration

March 4, 2015 · Leave a Comment 

  TG Therapeutics (NASDAQ: TGTX) an agreement with Checkpoint Therapeutics, Inc., a newly formed subsidiary of Coronado Biosciences, Inc. (Nasdaq: CNDO) to develop and commercialize Checkpoint’s fully human anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. Checkpoint will develop and commercialize these antibodies in solid tumors. The antibodies were generated in the laboratory of Dr. Wayne Marasco, MD, PhD, a Professor in the Department of Cancer Immunology and AIDs at Dana-Farber Cancer Institute (Dana-Farber). Both programs are currently... [Read the full story]

Legal

Asetek Announces Settlement of Lawsuit with CoolIT Systems, Inc.

February 6, 2015 · Leave a Comment 

  OSLO, Norway — Regulatory News: Asetek announces that it has settled its patent infringement lawsuit against CoolIT Systems, Inc. and agreed to dismiss the case (Asetek Danmark A/S v. CoolIT Systems, Inc., Northern District of California federal district court). Although the specific terms of the settlement are confidential, the parties have agreed to the federal district court making a determination of whether and to what extent damages are to be awarded by the court to Asetek. The court’s damages determination will be disclosed later in a separate release. About Asetek Asetek is the... [Read the full story]

Bio

Aduro Biopolymers Announce Technology Licensing Partnership

February 24, 2015 · Leave a Comment 

  HAMILTON, New Zealand – February 24, 2015 – Aduro Biopolymers LP and Wallace Corporation today announced they have signed an exclusive regional agreement with US-based Eastern BioPlastics, LLC (EBP) for the commercialization of EBP’s Feather Intermediate and Feathersorb TM. FeatherSorb™ is an environmentally-friendly cost-effective industrial absorbent product range engineered to provide better absorbency and cost performance for fuel, oil, paint and chemical solvent spills and clean up applications. FeatherSorb™ is made from poultry feathers which are processed into a Feather... [Read the full story]

University Tech Transfer

Pitt, UPMC reach commercialization agreement

February 22, 2015 · Leave a Comment 

  PITTSBURGH, Feb. 20, 2015 – The University of Pittsburgh and UPMC have entered into a new agreement designed to accelerate the commercialization of intellectual property arising from the research activity of University faculty. The partnership is intended to speed the commercialization of new medical technologies and services, offering the dual benefit of bringing medical advances to the public more rapidly and supporting new business startups, with the accompanying economic benefits for the region. This agreement builds on Pitt’s core mission of impacting society through knowledge... [Read the full story]

People

idealAsset signs Strategic Partner, Innovestion, LLC.

February 28, 2015 · Leave a Comment 

  AUSTIN, Texas, Feb. 26, 2015 /PRNewswire-iReach/ – idealAsset, a division of Fluid Innovation Group, Inc., announced new client Innovestion, LLC.  Innovestion acquires, manages and monetizes IP portfolios for Fortune 500, small and mid-cap companies, as well as individual inventors, generating substantial revenues from market relevant patents for the key stakeholders. “The IP Marketplace is going through a transformation and idealAsset is leading with its ability to rapidly match IP to opportunities.  We selected their platform to help scale our monetization efforts and expand... [Read the full story]

Deals

TG Therapeutics, Checkpoint Therapeutics Commercialization Collaboration

  TG Therapeutics (NASDAQ: TGTX) an agreement with Checkpoint Therapeutics, Inc., a newly formed subsidiary of Coronado Biosciences, Inc. (Nasdaq: CNDO) to develop and commercialize Checkpoint’s fully human anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. Checkpoint will develop and commercialize... Read more of this article


Brocade to Acquire Connectem

  SAN JOSE, CA and BARCELONA, SPAIN- March 1, 2015 - Brocade (NASDAQ: BRCD) today announced its intent to acquire Connectem, a privately-held company in the LTE virtual Evolved Packet Core (vEPC) market, in an all-cash transaction. The continued explosive growth of traditional mobile data combined with emerging requirements around machine-to-machine... Read more of this article


Ucore Secures Technology Rights

  HALIFAX, NOVA SCOTIA–(Marketwired – March 3, 2015) - Ucore Rare Metals Inc. (TSX VENTURE:UCU)(OTCQX:UURAF) (“Ucore” or “the Company”) is pleased to announce that it has entered into an agreement with IBC Advanced Technologies Inc. (“IBC”) to acquire the exclusive rights to IBC’s SuperLig®... Read more of this article


DuPont Protection Technologies and adidas Sign Agreement

  DuPont Protection Technologies (DuPont) and adidas Group North America (adidas) today announced the signing of a multi-year trademark license agreement for the use of the DuPont™ Kevlar® and Dare Bigger™ trademarks in football cleats. adidas recently previewed a limited edition line of cleats that incorporate DuPont™ Kevlar® fiber, and... Read more of this article


Blueprint Medicines Announces Collaboration with Alexion

  CAMBRIDGE, Mass., March 3, 2015 /PRNewswire/ — Blueprint Medicines today announced a strategic collaboration with Alexion to discover, develop and commercialize novel drug candidates for an undisclosed activated kinase target, which is the cause of a rare genetic disease. Blueprint Medicines will apply its kinase-focused drug discovery... Read more of this article


Amyris & Genome Compiler Partner

  EMERYVILLE and LOS ALTOS, Calif., March 3, 2015 (GLOBE NEWSWIRE) — Amyris, Inc. (Nasdaq:AMRS), an industrial bioscience company, and Genome Compiler Corp., a synthetic biology platform company, have entered into a collaboration agreement to integrate Amyris’s automated lab services with Genome Compiler’s online design tools... Read more of this article


SITRI Announces Collaboration BSAC at UC Berkeley

  BERKELEY, Calif. & SHANGHAI — The Shanghai Industrial µTechnology Research Institute (SITRI), a technical leader and R&D organization associated with the Shanghai Institute of Microsystem and Information Technology (SIMIT), Chinese Academy of Sciences, announced today it has entered into an agreement with the Berkeley Sensor and Actuator... Read more of this article


UAEU Licenses to Al Hameli Intnl Group

  The United Arab Emirates University (UAEU) recently granted a license to the Al Hameli International Group to make use of two patents to recycle carbon residues using nanotechnology. This agreement is for 12 to15 years. The two parties signed a licensing agreement while participating in the International Defense Exhibition and Conference (IDEX)... Read more of this article


APLAIR partners with ORNL

  OAK RIDGE, Tenn., March 2, 2015–With an aim toward automotive applications, Tennessee-based APLAIR Manufacturing Systems has licensed a weld inspection technology developed by the Department of Energy’s Oak Ridge National Laboratory. The automotive industry relies heavily on resistance spot welding in the fabrication and assembly... Read more of this article


WiLAN Enters into License Agreement with EV3 Inc. & Covidien

  OTTAWA, CANADA–(Marketwired – March 2, 2015) - WiLAN (TSX:WIN) (NASDAQ:WILN) today announced that the company’s subsidiary, Back Bay Medical Inc., has entered into a settlement and license agreement with EV3 Inc. and Covidien Holding Inc. The agreement resolves litigation that was pending in the United States District Court... Read more of this article


More Posts From Deals

Legal

Asetek Announces Settlement of Lawsuit with CoolIT Systems, Inc.

  OSLO, Norway — Regulatory News: Asetek announces that it has settled its... 


Tessera Technologies Reaches Global Settlement with Amkor

  SAN JOSE, Calif.–(BUSINESS WIRE)–Tessera Technologies, Inc. (NASDAQ:TSRA)... 


More Posts From Legal

University Tech Transfer

Pitt, UPMC reach commercialization agreement

  PITTSBURGH, Feb. 20, 2015 – The University of Pittsburgh and UPMC have... 


Cellectis and Ohio State University Enter Into Licensing Agreement

  Paris, January 13, 2015 – Cellectis SA (Alternext: ALCLS.PA) announces... 


More Posts From University Tech Transfer